Polio future or investigational therapies

Jump to navigation Jump to search

Polio Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Poliovirus

Differentiating Polio from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polio future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polio future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polio future or investigational therapies

CDC on Polio future or investigational therapies

Polio future or investigational therapies in the news

Blogs on Polio future or investigational therapies

Directions to Hospitals Treating Polio

Risk calculators and risk factors for Polio future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Although at the present moment there are no antiviral treatments for poliovirus, vaccination has shown to be an effective approach towards the eradication of the virus. Future studies are required in order to evaluate the best approach for immunization of the remaining endemic areas. Following the eradication of serotype 2, replacement of trivalent OPV for bivalent OPV has been discussed, thereby eliminating the risk of reinsurance of vaccine virus serotype 2.[1]

References

  1. Aylward B, Yamada T (2011). "The polio endgame". N Engl J Med. 364 (24): 2273–5. doi:10.1056/NEJMp1104329. PMID 21675884.

Template:WH Template:WS